$FOGC Up to date company activities and other important

New Post Public Reply Private Reply Replies (0) Message Board
Emylers
$FOGC Up to date company activities and other important information about $FOGC

$FOGC

DD Notes ~ http://www.ddnotesmaker.com/FOGC

##### recent news/filings ~ source: finance.yahoo.com

Mon, 30 Jun 2014 13:45:00 GMT ~ Fortune Oil and Gas announces name change and plans to improve share structure
- MILFORD, Pa., June 30, 2014 /PRNewswire/ -- Fortune Oil & Gas, Inc. (FOGC), today announced that the company has initiated filing for a voluntary name and symbol change with FINRA and the state of Wyoming. The change to Manzo Pharmaceuticals was filed with the state already and the company is in the process of providing FINRA the necessary documents to get it approved. The process has a 60 day deadline, but Manzo Pharmaceuticals feels it will be completed much sooner than that. The company has also put together a strategy to improve the share structure in an effort to get Manzo Pharmaceuticals off ground and moving along the way the company should be.
read full: http://finance.yahoo.com/news/fortune-oil-gas...00877.html
*********************************************************

Wed, 18 Jun 2014 17:04:07 GMT ~ FORTUNE OIL & GAS INC Financials
read full: http://finance.yahoo.com/q/is?s=fogc
*********************************************************

Tue, 17 Jun 2014 20:01:00 GMT ~ Manzo Pharmaceuticals announces the release of its newest product Tummy Relief a natural colic remedy for babies
- MILFORD, Pa., June 17, 2014 /PRNewswire/ -- Fortune Oil & Gas, Inc. (FOGC), today announced that its wholly owned subsidiary, Manzo Pharmaceuticals has released its first retail product to be available to the public. It is a remedy for babies with excess gas, which often causes a condition known as colic. The product, called Manzo's Tummy Relief, is currently available for purchase on Amazon.com. Colic is defined as periods of continuous crying for more than three hours per day, and although many other ailments can cause the condition, stomach and intestinal gas is often the culprit. Manzo's solution is a natural, safe and effective liquid given to the infant in the form of drops. Compared to competitors, Manzo's solution contains larger amounts of the effective ingredients, costs less, does not contain many unnatural or even harmful additives that other remedies do, and it comes in a unique spill proof bottle that avoids those frustrating spills and allows for more efficient use of the product with less waste. With competitor's products, it is difficult to get all of the liquid out of the bottle because of the design of the packaging causing waste, and costing consumers more money, but with Manzo's design, consumers can use every last drop in the bottle saving time and money.
read full: http://finance.yahoo.com/news/manzo-pharmaceu...00467.html
*********************************************************

Mon, 16 Jun 2014 12:00:00 GMT ~ Manzo Pharmaceuticals starts laboratory testing of its lactose intolerance probiotic treatment
- MILFORD, Pa., June 16, 2014 /PRNewswire/ -- Fortune Oil & Gas, Inc. (FOGC), today announced that the company's wholly owned subsidiary, Manzo Pharmaceuticals has begun a series of laboratory testing for its patented probiotic formula, Lacto-Freedom™. Lacto-Freedom™ is designed to stop the symptoms of lactose intolerance for up to several months after taking it for just a short time. The company started a six month long study with different dosages of the probiotic to find the optimum amount needed to achieve the desired effect. The safety of the product will also be confirmed over the course of this study and will prepare the product for human clinical trials. A stability test may also be performed to determine the best way to store the product and which dosage form is best (liquid, capsule, freeze dried powder, or pre-mixed in food) this study will bring Manzo Pharmaceuticals one-step closer to making this unique treatment available to the people who need it.
read full: http://finance.yahoo.com/news/manzo-pharmaceu...00680.html
*********************************************************

Wed, 11 Jun 2014 20:01:00 GMT ~ Fortune Oil & Gas announces major change in business direction with the acquisition of Manzo Pharmaceuticals
- MILFORD, Pa., June 11, 2014 /PRNewswire/ -- Fortune Oil & Gas, Inc. (FOGC), today announced that the company has acquired Manzo Pharmaceuticals, LLC., a private firm aiming to become a major force in the pharmaceutical industry. As part of the acquisition, Manzo Pharmaceutical's founder and President, Kenneth Manzo has been appointed CEO and Chairman of Fortune Oil & Gas, Inc. Manzo Pharmaceuticals, LLC is a specialty pharmaceutical company that is currently developing a range of innovative and affordable formulations for various drugs and supplements with innovative, patient-friendly and affordable solutions. The company's new CEO, Kenneth Manzo, is a licensed Pharmacist with 25 years of experience in the pharmaceutical industry.
read full: http://finance.yahoo.com/news/fortune-oil-gas...00512.html
*********************************************************

##### chart ~ source: stockcharts.com

stockcharts.com/c-sc/sc?s=FOGC&p=D&b=5&g=0&id=p95448242713

##### chart ~ source: eoddata.com

http://chart.eoddata.com/?e=OTCBB&s=FOGC&...D&b=BB

##### company info ~ source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/FOGC/company-info
Ticker: $FOGC
OTC Market Place: OTC Pink Current
CIK code: 0001119949
Company name: Fortune Oil & Gas, Inc.
Company website: http://manzopharma.com
Incorporated In: WY, USA

##### extra dd links

Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/FOGC/filings
Latest financials: http://www.otcmarkets.com/stock/FOGC/financials
Latest news: http://www.otcmarkets.com/stock/FOGC/news - http://finance.yahoo.com/q/h?s=FOGC+Headlines

Major holdings: http://data.cnbc.com/quotes/FOGC/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=FOGC+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/FOGC.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=FOGC

RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search

DTCC: http://search2.dtcc.com/?q=Fortune+Oil+%26+Ga...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...Gas%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
WHOIS: http://whois.domaintools.com/http://manzopharma.com
Alexa: http://www.alexa.com/siteinfo/http://manzopharma.com#
Corporate website internet archive: http://web.archive.org/web/*/http://manzopharma.com

Short Sales: http://www.otcmarkets.com/stock/FOGC/short-sales
Insider Disclosure: http://www.otcmarkets.com/stock/FOGC/insider-transactions
Research Reports: http://www.otcmarkets.com/stock/FOGC/research
Historical Prices: http://finance.yahoo.com/q/hp?s=FOGC+Historical+Prices
Basic Tech. Analysis: http://finance.yahoo.com/q/ta?s=FOGC+Basic+Tech.+Analysis
Company Profile: http://finance.yahoo.com/q/pr?s=FOGC+Profile
Key Statistics: http://finance.yahoo.com/q/ks?s=FOGC+Key+Statistics
Industry: http://finance.yahoo.com/q/in?s=FOGC+Industry
Insider Roster: http://finance.yahoo.com/q/ir?s=FOGC+Insider+Roster
Income Statement: http://finance.yahoo.com/q/is?s=FOGC
Balance Sheet: http://finance.yahoo.com/q/bs?s=FOGC
Cash Flow: http://finance.yahoo.com/q/cf?s=FOGC+Cash+Flow&annual
Market Watch: http://www.marketwatch.com/investing/stock/FOGC
Bloomberg: http://www.bloomberg.com/quote/FOGC:US
Morningstar: http://quotes.morningstar.com/stock/s?t=FOGC
Bussinessweek: http://investing.businessweek.com/research/st...icker=FOGC
Barchart: http://www.barchart.com/quotes/stocks/FOGC
OTC Short Report: http://otcshortreport.com/index.php?index=FOGC
Investopedia: http://www.investopedia.com/markets/stocks/FOGC/?wa=0

http://www.pennystocktweets.com/stocks/profile/FOGC

##### last known share structure ~ source: otcmarkets.com

Market Value: $1,342,606 a/o Jun 27, 2014
Shares Outstanding: 2,685,211,678 a/o Jun 05, 2014
Float: 2,498,858,639 a/o Jun 05, 2014
Authorized Shares: 5,000,000,000 a/o Jun 05, 2014
Par Value: 0.001

##### business description ~ source: otcmarkets.com

Fortune Oil & Gas, Inc. is an Oil & Gas company that recently acquired Manzo Pharmaceuticals, LLC. This new wholly owned subsidiary is a specialty pharmaceutical company that is developing a range of innovative and affordable formulations for various drugs and supplements. Manzo Pharmaceuticals is focused on addressing the unmet medical needs of patients with innovative, patient-friendly and affordable solutions. Manzo Pharmaceuticals is currently engaged in research and development of a patented new experimental product that will help people with lactose intolerance by removing the symptoms for months at a time after taking it only for a short time. Other products include a safe and natural solution for babies with colic, gas, and stomach discomfort that will be released for sale to the public very shortly.Less >>

DD Notes ~ http://www.ddnotesmaker.com/FOGC

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Louisiana's Musical Legacy Gets a Boost from Foundation

Updated Category News Views 201

Preserving the Tunes of the Bayou Well, if that ain't music to your ears! The Louisiana First Horizon Foundation is sliding into the spotlight with news that's bound to strike a chord with any lover of the state's iconic rhythms. They're diving in deep, backing the Louisiana Music Museum right in the heart of Lafayette. Now, that ain't just another charity stunt; it's a...

Continue Reading
ecozy's Brezzano Switch: Brewing Simplicity at Home

Updated Category News Views 151

Breathe the aroma, sip the innovation. ecozy just threw their Brezzano Switch into the arena, and here's the deal: it's a no-nonsense, get-your-caffeine-fix kind of machine aimed at making your mornings simple without compromising on flavor. Unique Features of the Brezzano Switch So, what's cooking? Get this—it's not just any coffee contraption. Built sleek and compact,...

Continue Reading
Future FinTech Under Investigation: Shareholder Impact Looms

Updated Category News Views 81

Future FinTech Faces Legal Scrutiny When the walls close in under financial suspicion, the spotlight can burn brighter than any anticipated market gain. That's precisely what Future FinTech Group Inc. (NasdaqCM: FTFT) is up against now. Kahn Swick & Foti, LLC, featuring the ex-Attorney General of Louisiana, Charles C. Foti, Jr., has begun scrutinizing the actions of...

Continue Reading
AXON Revenue Forecast Cut Spurs Legal Investigation

Updated Category News Views 135

Axon's Revenue Forecast Takes a Hit Listen up, folks. Axon Enterprise, Inc. (NASDAQ: AXON) has stirred the pot, cutting their 2026 revenue forecast faster than you can say "counter-drone deployment." Back in August, they were riding high on their second-quarter call, raising their growth forecast to a cheerful 32%-34%. Fast forward to November, and it's been slashed to...

Continue Reading
Cultural Bridges and Mazu's Spirit: Gen Z's Role

Updated Category News Views 138

Youthful Energy Revives Ancient Traditions Over in Putian, China, you'd have seen a curious sight in late October—hundreds of young folks from over 20 corners of the globe gathering not for a concert or some influencer meet-up, but to dive into Mazu's legacy. This ain't your typical cultural event. More than 200 Gen Z representatives came together, bridging their...

Continue Reading
Adding Fireplaces: Home Comfort or Construction Headache?

Updated Category News Views 73

Sizing Up the Installation Options Slapping a fireplace into a home sounds more like a pipe dream than a practical project for most folks. But according to fireplace whiz Jimmy Smith down in North Charleston, the times are a-changin'. These days, with advances in technology, homeowners can actually pull it off without collapsing their living room walls. Nitty-Gritty:...

Continue Reading
CleanSpark Sets Investor Events with Promising Outlook

Updated Category News Views 184

CleanSpark's Strategy Gets the Spotlight Looks like CleanSpark's stepping up to the plate, folks. They're shouting from the rooftops about hitting the upcoming investor events, and it’s no small potatoes. The company’s lined up a string of high-profile conferences, showcasing their ambition to stay ahead in the energy and data center games. We're talking about the...

Continue Reading
Century Lithium's 2026 AGM Time Clarification Issued

Updated Category News Views 129

Time Zone Confusion No More Ah, time zones. They just keep finding ways to trip up the folks at Century Lithium. The company’s got itself in a twist over when the Annual General Meeting's supposed to kick off. Turns out, they've clarified the timing for their 2026 AGM—it’s stamped for 10:00 a.m. Pacific Time. British Columbia’s ditched the seasonal time change, so...

Continue Reading
FuelCell Faces Class Action Crunch as Deadline Looms

Updated Category News Views 77

FuelCell's Legal Storm: What to Know Now You ever get that feeling when your gut knows it all before you even finish reading the headline? Well, buckle up, because FuelCell Energy, Inc. (NASDAQ:FCEL) is staring down a potential class-action train wreck, and they ain't got much track left to skid on before the deadline hits hard on November 10th, 2026. The Crunchy Details...

Continue Reading
AZZ Inc.'s 2026 Sustainability Report: A Closer Look

Updated Category News Views 231

Diving into AZZ's Sustainability Commitment AZZ Inc., known in the trading circles as NYSE:AZZ, has just dropped its 2026 Sustainability Report and it’s quite the document to chew on. This ain't your typical corporate fluff. Tom Ferguson, the man steering the AZZ ship, laid it down plain and simple. This report isn’t just about ticking boxes for ESG; it’s reflecting...

Continue Reading

Top 5 Most Recently Viewed Articles

ImmunityBio Advances Towards EU Approval for Cancer Treatment

Updated Category News Views 95

ImmunityBio's Journey Towards EU Approval The European Medicines Agency (EMA) has made a significant recommendation toward approving ImmunityBio, Inc.’s Anktiva (nogapendekin alfa inbakicept), intended for use alongside Bacillus Calmette-Guérin (BCG) for treating BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). Clinical Trial Results and Findings This...

Continue Reading
Temperature Monitoring Systems Set to Reach $5.66 Billion by 2030

Updated Category News Views 139

Temperature Monitoring Systems Market Analysis and Growth Projections The temperature monitoring systems market, valued at USD 3.80 billion recently, is on a promising trajectory. It is expected to expand at a compound annual growth rate (CAGR) of 5.3%, reaching an impressive USD 5.66 billion by 2030. This growth can be attributed to several factors, including...

Continue Reading
Comparative Insights on Apple and Its Competitors' Performance

Updated Category News Views 336

Performance Insights into Apple and Industry Competitors In the ever-evolving realm of technology, understanding the dynamics of company performance is vital for investors and analysts. This analysis focuses on Apple Inc. (NASDAQ: AAPL) and its key competitors in the Technology Hardware, Storage & Peripherals sector. We'll delve into essential financial metrics, market...

Continue Reading
X Financial Achieves Impressive Growth in Recent Earnings

Updated Category News Views 108

X Financial Reveals Strong Q2 Performance X Financial (NYSE: XYF), a prominent player in the fintech industry, has reported robust financial results that highlight its significant growth and commitment to enhancing its service offering. The company recently disclosed its unaudited financial results for the second quarter, and the figures are quite remarkable. Q2 2025...

Continue Reading
Tyra Biosciences to Engage Investors at Major Conferences

Updated Category News Views 290

Tyra Biosciences to Engage Investors at Major Conferences Tyra Biosciences, Inc. (Nasdaq: TYRA) is a pioneering biotechnology company dedicated to crafting next-generation precision medicines with a keen focus on Fibroblast Growth Factor Receptor (FGFR) biology. The company has great momentum as it takes strides in engaging with investors at a series of crucial investor...

Continue Reading